重性抑郁多基因风险评分的诊断特异性与发育轨迹:巴西混合血统青少年队列研究
该研究在巴西高风险队列两个站点(N=2163,6-23岁)采用发现-复制设计,检验重性抑郁多基因风险评分(MDD-PRS)与终身DSM-IV诊断、抑郁症状纵向轨迹及青少年晚期/成年早期抑郁症状和非自杀性自伤(NSSI)的关联。结果显示MDD-PRS对MDD具有相对诊断特异性,可解释约2.6%至3.6%的易感性方差,并预测抑郁症状更严重的发育轨迹,NSSI关联仅在MDD诊断者中显著。
要点
- MDD-PRS对MDD诊断具有相对特异性,解释约2.6%至3.6%易感性方差,其他诊断类别未通过FDR校正。
- 较高MDD-PRS预测抑郁症状初始水平更高(β=0.10-0.18)、增长更快(β=0.07-0.10)及时间平均水平更高(β=0.13-0.20)。
- MDD-PRS与NSSI主效应关联(β=0.09)仅在MDD诊断者的事后交互分析中保持显著(β=0.24)。
核心结论
- 在深度表型化的混合血统青少年队列中,MDD-PRS表现出相对诊断特异性,并标记出更严重的抑郁发育轨迹。
- NSSI与MDD-PRS的关联取决于MDD诊断,支持MDD-PRS的相对特异性、发育效用及跨血统相关性。
研究设计与样本
- 研究在巴西高风险队列两个站点进行,样本N=2163,年龄6-23岁,女性占45.6%,采用发现-复制设计。
- 分析使用加权普通最小二乘和分位数回归,调整年龄、性别、社会经济地位、遗传主成分及精神科共病。
主要发现
- MDD-PRS在两个站点均显示对MDD的相对特异性,解释约2.6%至3.6%的易感性方差,其他诊断类别未通过错误发现率校正。
- 纵向分析中,较高MDD-PRS预测抑郁症状初始水平更高(β=0.10-0.18;两站点p<.001)、增长速率更快(β=0.07-0.10;p=.004和p<.001)及时间平均水平更高(β=0.13-0.20;两站点p<.001),效应在高分位数处增强。
- 横断面分析中,MDD-PRS与更多抑郁症状相关(β=0.15-0.17;两站点p<.001)。
- 对于NSSI,观察到主效应关联(β=0.09;p<.001),但仅在MDD诊断者的事后MDD-PRS×终身MDD交互分析中保持显著(β=0.24;p=.014)。
关键数值与推荐
- MDD-PRS解释MDD易感性方差的约2.6%至3.6%,其他诊断类别未通过错误发现率校正。
- 抑郁症状初始水平β=0.10-0.18(两站点p<.001),增长速率β=0.07-0.10(p=.004和p<.001),时间平均水平β=0.13-0.20(两站点p<.001)。
- 横断面抑郁症状β=0.15-0.17(两站点p<.001);NSSI主效应β=0.09(p<.001),交互分析中β=0.24(p=.014)。
临床怎么用
- MDD-PRS可作为识别抑郁更严重发育轨迹风险的潜在生物标志物,但解释方差有限,不宜单独用于临床预测。
- NSSI风险关联在MDD诊断者中更明显,提示临床评估NSSI时应结合MDD诊断状态。
- 跨血统混合队列中的相对特异性支持MDD-PRS在不同 ancestry 背景下的潜在适用性。
局限性
- 研究样本为巴西高风险队列的混合血统青少年,结果外推至其他人群需谨慎。
- MDD-PRS解释的方差比例较小(约2.6%至3.6%),临床效用有限。
- NSSI关联仅在事后交互分析中显著,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Major depressive disorder (MDD) is heritable and polygenic, yet the relative diagnostic specificity, developmental impact, and cross-ancestry generalizability of MDD polygenic risk scores (MDD-PRSs) remain unclear. METHODS: At 2 sites of the Brazilian High-Risk Cohort (N = 2163; ages 6-23 years; 45.6% female), we used a discovery-replication design to test associations between MDD-PRSs and 1) lifetime DSM-IV diagnoses, 2) longitudinal depressive-symptom trajectories derived from latent growth-curve models, and 3) late-adolescent/young-adult depressive symptoms and nonsuicidal self-injury (NSSI). Analyses used weighted ordinary least squares and quantile regression, adjusting for age, sex, socioeconomic status, genetic principal components, and psychiatric comorbidity. RESULTS: MDD-PRSs showed relative specificity for MDD in both sites, explaining approximately 2.6% to 3.6% of the liability-scale variance; no other diagnostic category survived false discovery rate correction. Longitudinally, higher MDD-PRSs predicted a higher initial level (β = 0.10-0.18; p < .001 in both sites), a faster rate of increase (β = 0.07-0.10; p = .004 and p < .001), and a higher time-averaged level (β = 0.13-0.20; p < .001 in both sites) of depressive symptoms, with effects strengthening at higher quantiles. Cross-sectionally, MDD-PRSs were associated with more depressive symptoms (β = 0.15-0.17; p < .001 in both sites). For NSSI, a main-effect association was observed (β = 0.09; p < .001), but it remained significant only in a post hoc MDD-PRS × lifetime-MDD interaction among individuals with MDD (β = 0.24; p = .014). CONCLUSIONS: In this deeply phenotyped, admixed cohort, MDD-PRSs showed relative diagnostic specificity and marked a more severe developmental course of depression, with NSSI associations contingent on MDD diagnosis, supporting the relative specificity, developmental utility, and cross-ancestry relevance of MDD-PRSs.
引用
- Brañas MJAA, Ito LT, Croci MS, et al. Polygenic Risk for Major Depression: Diagnostic Specificity and Developmental Trajectories in an Admixed Youth Cohort. Biol Psychiatry. 2026. PMID: 42462945. doi:10.1016/j.biopsych.2026.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。